AMRX Award Disclosure
Patel Chintu · SEC Form 4 · Filed Aug 12, 2026
Award
Reported value range
Not reported
Patel Chintu Co-CEO
AMRX
Transaction date
Aug 10, 2026
Public filing date
Aug 12, 2026
Filing lag
Filed 2 days later
AMRX daily price context
Close on/before transaction
$17.88
Aug 10, 2026
Close before public filing
$17.1
Aug 11, 2026
Return since public filing
-0.53%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Class A Common Stock
- Quantity / price
- 6,381,734 shares
- SEC ownership
- Indirect
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001628280-26-056297
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Amneal Pharmaceuticals, Inc. AMRX Current | Award | Aug 10, 2026 | Not reported |